Catherine Park, MD

Chair, Department of Radiation Oncology
Radiation oncologist

Dr. Catherine Park is a radiation oncologist with a special interest in the treatment of lymphoma and breast cancer. She earned a medical degree at the UCLA School of Medicine and completed a residency in radiation oncology at the Joint Center for Radiation Oncology at Harvard Medical School. After serving as a visiting scientist at the Lawrence Berkeley National Laboratory, Park joined UCSF Medical Center, where she is chair of the department of radiation oncology.

She is the recipient of numerous awards, including the Upjohn Achievement Award and C. Donald O'Malley Prize in the History of Medicine. Park is a clinical professor of radiation oncology at the University of California, San Francisco.

Clinics

Radiation Oncology at Mount Zion
1600 Divisadero St., Basement Level
San Francisco, CA 94143-1708
Main Phone: (415) 353-7175
New Patient Appointments: (415) 353-9807
Fax: (415) 353-9884

Hours: Monday to Friday
7 a.m. – 6 p.m.

Radiation Oncology at Parnassus
505 Parnassus Ave, Room L-75
San Francisco, CA 94143-0226
Main Phone: (415) 353-7175
New Patient Appointments: (415) 353-8335
Fax: (415) 353-7281

Hours: Monday to Friday
8 a.m. – 4:30 p.m.

Conditions & Treatments

Board Certification

Radiation Oncology, American Board of Radiology

Academic Title

Professor
Interim Chair

More about Catherine Park

Education

UCLA Medical Center 1995

Residencies

Harvard Medical School, Radiation Oncology 2000

Selected Research and Publications

  1. Papageorgiou EP, Zhang H, Boser BE, Park C, Anwar M. Angle-insensitive amorphous silicon optical filter for fluorescence contact imaging. Opt Lett. 2018 Feb 01; 43(3):354-357.
  2. Fowble B, Jairam AK, Wang F, Peled A, Alvarado M, Ewing C, Esserman L, Park C, Lazar A. Indications for Postmastectomy Radiation After Neoadjuvant Chemotherapy in ypN0 and ypN1-3 Axillary Node-Positive Women. Clin Breast Cancer. 2018 Feb; 18(1):e107-e113.
  3. Johnson J, Esserman L, Ewing C, Alvarado M, Park C, Fowble B. Sentinel Lymph Node Mapping in Post-Mastectomy Chest Wall Recurrences: Influence on Radiation Treatment Fields and Outcome. Ann Surg Oncol. 2016 Mar; 23(3):715-21.
  4. Lin CH, Pelissier FA, Zhang H, Lakins J, Weaver VM, Park C, LaBarge MA. Microenvironment rigidity modulates responses to the HER2 receptor tyrosine kinase inhibitor lapatinib via YAP and TAZ transcription factors. Mol Biol Cell. 2015 Nov 05; 26(22):3946-53.
  5. Fowble B, Park C, Wang F, Peled A, Alvarado M, Ewing C, Esserman L, Foster R, Sbitany H, Hanlon A. Rates of Reconstruction Failure in Patients Undergoing Immediate Reconstruction With Tissue Expanders and/or Implants and Postmastectomy Radiation Therapy. Int J Radiat Oncol Biol Phys. 2015 Jul 01; 92(3):634-41.
  6. Sethi R, Park C, Fowble B. Postmastectomy radiotherapy in patients with breast cancer. Lancet. 2014 Nov 22; 384(9957):1845.
  7. Alvarado MD, Conolly J, Park C, Sakata T, Mohan AJ, Harrison BL, Hayes M, Esserman LJ, Ozanne EM. Patient preferences regarding intraoperative versus external beam radiotherapy following breast-conserving surgery. Breast Cancer Res Treat. 2014 Jan; 143(1):135-40.
  8. Descovich M, Fowble B, Bevan A, Schechter N, Park C, Xia P. Comparison between hybrid direct aperture optimized intensity-modulated radiotherapy and forward planning intensity-modulated radiotherapy for whole breast irradiation. Int J Radiat Oncol Biol Phys. 2010 Jan 01; 76(1):91-9.
  9. Park CC, Zhang HJ, Yao ES, Park CJ, Bissell MJ. Beta1 integrin inhibition dramatically enhances radiotherapy efficacy in human breast cancer xenografts. Cancer Res. 2008 Jun 01; 68(11):4398-405.
  10. Hattangadi J, Park C, Rembert J, Klifa C, Hwang J, Gibbs J, Hylton N. Breast stromal enhancement on MRI is associated with response to neoadjuvant chemotherapy. AJR Am J Roentgenol. 2008 Jun; 190(6):1630-6.
  11. Park CK, Miller C, Lawrence G. Addison's disease from non-Hodgkin's lymphoma with normal-size adrenal glands. J Clin Oncol. 2007 Jun 01; 25(16):2322-4.
  12. Yao ES, Zhang H, Chen YY, Lee B, Chew K, Moore D, Park C. Increased beta1 integrin is associated with decreased survival in invasive breast cancer. Cancer Res. 2007 Jan 15; 67(2):659-64.
  13. Coleman J, Park C, Villarreal-Barajas JE, Petti P, Faddegon B. A comparison of Monte Carlo and Fermi-Eyges-Hogstrom estimates of heart and lung dose from breast electron boost treatment. Int J Radiat Oncol Biol Phys. 2005 Feb 01; 61(2):621-8.
  14. Park C, Seid P, Morita E, Iwanaga K, Weinberg V, Quivey J, Hwang ES, Esserman LJ, Leong SP. Internal mammary sentinel lymph node mapping for invasive breast cancer: implications for staging and treatment. Breast J. 2005 Jan-Feb; 11(1):29-33.

Publications are derived from MEDLINE/PubMed and provided by UCSF Profiles, a service of the Clinical & Translational Science Institute (CTSI) at UCSF. Researchers can make corrections and additions to their publications by logging on to UCSF Profiles.